Triveni Bio October 2024 Series B Funding Round
Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disorders
Is a
Announcement URL
Funded Company
Funding Round Date
October 2, 2024
Funding Round Amount (USD)
115,000,000
Funding Type
Find more entities like Triveni Bio October 2024 Series B Funding Round
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
